1. Home
  2. EBS vs CLCO Comparison

EBS vs CLCO Comparison

Compare EBS & CLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EBS
  • CLCO
  • Stock Information
  • Founded
  • EBS 1998
  • CLCO 2018
  • Country
  • EBS United States
  • CLCO United Kingdom
  • Employees
  • EBS N/A
  • CLCO N/A
  • Industry
  • EBS Biotechnology: Pharmaceutical Preparations
  • CLCO
  • Sector
  • EBS Health Care
  • CLCO
  • Exchange
  • EBS Nasdaq
  • CLCO Nasdaq
  • Market Cap
  • EBS 423.6M
  • CLCO 503.8M
  • IPO Year
  • EBS 2006
  • CLCO N/A
  • Fundamental
  • Price
  • EBS $9.11
  • CLCO $9.68
  • Analyst Decision
  • EBS Strong Buy
  • CLCO
  • Analyst Count
  • EBS 2
  • CLCO 0
  • Target Price
  • EBS $13.50
  • CLCO N/A
  • AVG Volume (30 Days)
  • EBS 969.4K
  • CLCO 500.7K
  • Earning Date
  • EBS 10-29-2025
  • CLCO 11-19-2025
  • Dividend Yield
  • EBS N/A
  • CLCO 6.21%
  • EPS Growth
  • EBS N/A
  • CLCO N/A
  • EPS
  • EBS 2.53
  • CLCO 1.04
  • Revenue
  • EBS $851,600,000.00
  • CLCO $322,034,000.00
  • Revenue This Year
  • EBS N/A
  • CLCO $4.79
  • Revenue Next Year
  • EBS $19.24
  • CLCO N/A
  • P/E Ratio
  • EBS $3.63
  • CLCO $9.04
  • Revenue Growth
  • EBS N/A
  • CLCO N/A
  • 52 Week Low
  • EBS $4.02
  • CLCO $4.51
  • 52 Week High
  • EBS $12.73
  • CLCO $11.63
  • Technical
  • Relative Strength Index (RSI)
  • EBS 54.66
  • CLCO 75.46
  • Support Level
  • EBS $9.07
  • CLCO $7.62
  • Resistance Level
  • EBS $10.10
  • CLCO $9.57
  • Average True Range (ATR)
  • EBS 0.49
  • CLCO 0.05
  • MACD
  • EBS 0.01
  • CLCO -0.01
  • Stochastic Oscillator
  • EBS 53.00
  • CLCO 85.42

About EBS Emergent Biosolutions Inc.

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.

About CLCO Cool Company Ltd.

Cool Co Ltd is a LNG shipping company. The company is engaged in the acquisition, ownership, operation and chartering of liquefied natural gas (LNG) carriers (LNGCs), and the operation of third party fleets under management agreements. The company manages its business through a single operating and reporting segment, the LNG carrier market.

Share on Social Networks: